Altermune launches with Mullis as CSO

Kary Mullis, the Nobel Prize winning inventor of PCR, and VC firm Loxbridge Research formed Altermune Technologies LLC (Orange County, Calif.) to develop therapeutics for drug-resistant pathogens. Loxbridge will provide up to $7 million in milestone-based seed financing. Mullis is CSO of the newco, while Loxbridge CEO Charles Roberts is president for an initial development period. ...